Results for “Parkinson's disease”
Parkinsons Disease
Parkinson's disease is a neurodegenerative disorder that affects movement, balance, and other bodily functions, causing a range of motor and non-motor symptoms that can significantly impact a person's quality of life.
Health & MedicineDeep Brain Stimulation
** Deep brain stimulation (DBS) is a surgically implanted neurostimulation therapy that delivers precise electrical pulses to targeted brain regions to modulate abnormal neural circuits in a variety of chronic neurological disorders. **CONTENT:** ## Overview Deep brain stimulation (DBS) is a **neurostimulation** technique that uses an implantable pulse generator (IPG) placed under the skin of the chest, connected via insulated leads to specific deep brain nuclei. The device emits controlled electrical impulses that **bidirectionally** influence neuronal activity—both **ante‑grade** (forward) and **retrograde** (backward) signaling—thereby disrupting pathological circuit patterns while promoting more normal firing. Unlike lesioning procedures that permanently destroy tissue, DBS is adjustable, reversible, and can be fine‑tuned over time to match a patient’s evolving symptoms. Clinically, DBS is most widely recognized for its ability to alleviate **Parkinsonian tremor**, rigidity, and bradykinesia, but its therapeutic reach now includes **essential tremor**, **dystonia**, **obsessive‑compulsive disorder (OCD)**, **Tourette syndrome**, **epilepsy**, and emerging applications in **depression**, **Alzheimer’s disease**, and **chronic pain**. Candidates typically have medication‑refractory disease, and the decision to proceed involves a multidisciplinary team of neurologists, neurosurgeons, neuropsychologists, and rehabilitation specialists. **Important safety note:** If you or a loved one are considering DBS, consult a qualified neurologist or neurosurgeon for a comprehensive evaluation; DBS carries surgical risks and requires lifelong device management. ## History/Background The conceptual roots of DBS trace back to the 1960s, when researchers first observed that high‑frequency electrical stimulation could suppress abnormal neuronal firing in animal models. In 1987, **Alim-Louis Benabid** and colleagues demonstrated that chronic high‑frequency stimulation of the **ventral intermediate nucleus (VIM)** of the thalamus markedly reduced tremor in Parkinson’s patients, marking the first successful human application. The early 1990s saw the FDA grant **Humanitarian Device Exemption** for DBS in essential tremor, followed by a **1997 approval** for Parkinson’s disease. Throughout the 2000s, advances in imaging (MRI‑guided targeting), electrode design (directional leads), and IPG technology (programmable, rechargeable batteries) expanded the therapeutic landscape. In 2011, the FDA approved DBS for **essential tremor**, and in 2018 for **refractory OCD**. Ongoing clinical trials continue to explore DBS for **treatment‑resistant depression**, **Alzheimer’s disease**, and **obesity**, reflecting a shift from a purely motor‑disorder focus to broader neuropsychiatric applications. ## Key Information - **Device components:** IPG (battery‑powered pulse generator), lead(s) with multiple contacts, and a programmer for external adjustments. Modern IPGs may be **rechargeable** and capable of **closed‑loop** sensing, adjusting stimulation in real time based on neural feedback. - **Target nuclei:** Common targets include the **subthalamic nucleus (STN)** and **globus pallidus internus (GPi)** for Parkinson’s disease; the **VIM** for essential tremor; the **anterior limb of the internal capsule** for OCD; and the **centromedian thalamic nucleus** for certain epilepsy syndromes. - **Surgical procedure:** Performed under stereotactic guidance, the surgery involves drilling a burr hole, inserting the lead, and tunneling the extension to the chest where the IPG is implanted. Intra‑operative microelectrode recordings help refine placement. - **Efficacy:** Meta‑analyses report **30‑60% improvement** in motor scores for Parkinson’s disease and **50‑70% reduction** in tremor amplitude for essential tremor. Psychiatric indications show variable response, with roughly **40‑50%** of OCD patients achieving clinically meaningful improvement. - **Risks & complications:** Include infection, hemorrhage, lead migration, hardware failure, and stimulation‑related side effects such as dysarthria, paresthesia, or mood changes. Regular follow‑up is essential to balance therapeutic benefit against adverse effects. - **Regulatory status:** FDA‑approved for Parkinson’s disease, essential tremor, dystonia, and OCD; many other uses remain **off‑label** or under investigational study. ## Significance DBS represents a paradigm shift in neuromodulation, offering a **reversible, adjustable** alternative to ablative brain surgery. Its capacity to modulate dysfunctional circuits without destroying tissue has transformed the management of movement disorders, granting many patients restored independence and quality of life. The technology also serves as a **research platform**, allowing scientists to probe the causal role of specific brain networks in cognition, emotion, and behavior. Beyond individual patient benefit, DBS has spurred interdisciplinary collaboration among neurosurgery, biomedical engineering, neurophysiology, and psychiatry, accelerating innovations such as **directional leads**, **adaptive closed‑loop systems**, and **machine‑learning‑driven programming**. As the field matures, DBS may become a cornerstone of personalized medicine for a spectrum of neuropsychiatric conditions, illustrating how precise electrical modulation can complement pharmacologic and behavioral therapies. **INFOBOX:** - Name: Deep Brain Stimulation (DBS) - Type: Implantable neurostimulation therapy - Date: First human use 1987 (Benabid) - Location: Operates within deep brain nuclei; IPG implanted sub‑clavicularly - Known For: Reversible electrical modulation of pathological brain circuits for movement and psychiatric disorders **TAGS:** deep brain stimulation, neurostimulation, Parkinson's disease, essential tremor, neurosurgery, brain implants, neuromodulation, psychiatric disorders
Health & MedicineAcetyl L Carnitine
Acetyl-L-carnitine (ALCAR) is a naturally occurring amino acid derivative that plays a crucial role in energy production, brain function, and overall health. ## Overview Acetyl-L-carnitine (ALCAR) is a naturally occurring amino acid derivative that is produced by the human body and is also available as a dietary supplement. It is an acetylated form of L-carnitine, which is an essential nutrient that helps transport fatty acids into the mitochondria for energy production. ALCAR is broken down in the blood by plasma esterases to carnitine, which is then used by the body to facilitate energy production. This process is particularly important for the brain, where ALCAR helps to support the production of energy and protect against oxidative stress. ALCAR has been shown to have a range of benefits, including improving cognitive function, reducing fatigue, and enhancing overall health. It has also been used to support the treatment of various medical conditions, including Alzheimer's disease, Parkinson's disease, and depression. While ALCAR is generally considered safe, it is essential to consult with a healthcare professional before taking it as a supplement, as high doses may interact with certain medications or have adverse effects in certain individuals. ## History/Background Acetyl-L-carnitine was first isolated in the 1970s, and since then, it has been extensively studied for its potential health benefits. Early research focused on its role in energy production and its potential to support the treatment of various medical conditions. In the 1990s, ALCAR gained popularity as a dietary supplement, and it has since become widely available in health food stores and online. ## Key Information - **Mechanism of Action**: ALCAR is broken down in the blood by plasma esterases to carnitine, which is then used by the body to transport fatty acids into the mitochondria for energy production. - **Benefits**: ALCAR has been shown to improve cognitive function, reduce fatigue, and enhance overall health. - **Medical Conditions**: ALCAR has been used to support the treatment of various medical conditions, including Alzheimer's disease, Parkinson's disease, and depression. - **Dietary Sources**: ALCAR is found in small amounts in certain foods, including meat, fish, and dairy products. - **Supplementation**: ALCAR is available as a dietary supplement in various forms, including capsules, tablets, and powders. ## Significance ALCAR is significant because of its potential to support the treatment of various medical conditions and its role in energy production. Its ability to improve cognitive function and reduce fatigue makes it a popular dietary supplement among individuals looking to enhance their overall health and well-being. Additionally, ALCAR's potential to support the treatment of Alzheimer's disease and other neurodegenerative disorders makes it an area of ongoing research and interest. INFOBOX: - Name: Acetyl-L-carnitine (ALCAR) - Type: Amino acid derivative - Date: First isolated in the 1970s - Location: Widely available as a dietary supplement - Known For: Supporting energy production, cognitive function, and overall health TAGS: Acetyl-L-carnitine, ALCAR, L-carnitine, energy production, cognitive function, Alzheimer's disease, Parkinson's disease, depression, dietary supplement, amino acid derivative.